Your new experience awaits. Try the new design now and help us make it even better

METHODS article

Front. Immunol.

Sec. Viral Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1690316

The effects of Cryopreservation on PBMCs transcriptome profile

Provisionally accepted
Xuan  LiXuan LiQian  ChenQian ChenJeanette  HigginsJeanette HigginsKyndal  CookKyndal CookMichael  W. BaselerMichael W. BaselerTomozumi  ImamichiTomozumi Imamichi*Weizhong  ChangWeizhong Chang*
  • Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick (NIH), Frederick, United States

The final, formatted version of the article will be published soon.

Cryopreservation is a key method for long-term storage of biological specimens. The development of optimal cryopreservation and recovery conditions will minimize storage-related damage. The effect of the cryopreservation and recovery condition we used on peripheral blood mononuclear cells (PBMCs) has previously been evaluated using microarray analysis. The emerging single-cell RNA sequencing (scRNA-seq) technology enables deeper exploration of cellular heterogeneity and function. In the current study, we further optimized the cryopreservation and recovery procedure based on cell viability of PBMC cryopreserved for one-year evaluated using trypan blue staining and propidium iodide (PI) staining with FACS. The procedure was further validated by scRNA-seq using PBMC cryopreserved for two different lengths of time: six and 12 months, in comparison with fresh cells. We identified six major immune cell types from both fresh and recovered cryopreserved PBMCs, including monocytes, dendritic cells (DCs), natural killer (NK) cells, CD4+ T cells, CD8+ T cells, and B cells. The cell viability of all identified immune cell types was relatively stable after both six and 12 months of cryopreservation; however, the number of cells sequenced in the scRNA-seq data declined significantly by ~32% after 12 months of cryopreservation, suggesting reduced scRNA-seq cell capture efficiency. Furthermore, the transcriptome profiles of cryopreserved samples did not show substantial perturbation over the 12-month testing period, although a few key genes involved in AP-1 complex, stress response or response to calcium ion exhibited significant change, but with very small scale (< two folds). In conclusion, even though we observed a reduction of scRNA-seq cell capture efficiency after 12-month cryopreservation, our results demonstrated that the optimized cryopreservation and recovery procedure has minimal effect on PBMC viability, population composition and transcriptomic profiles after 6 or 12 months of storage.

Keywords: PBMC, Cryopreservation, ScRNA-seq, immune cell, viability

Received: 21 Aug 2025; Accepted: 06 Oct 2025.

Copyright: © 2025 Li, Chen, Higgins, Cook, Baseler, Imamichi and Chang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Tomozumi Imamichi, timamichi@mail.nih.gov
Weizhong Chang, weizhong.chang@nih.gov

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.